What they were paid
MBX Biosciences Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $48,000 | $0 | $146,947 | $0 | $194,947 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: MBX Biosciences, Inc. DEF 14A filed April 22, 2026, accession 0001193125-26-168536, and prior-year filings. Open the filing on EDGAR.
Committees
FY2025 · as the proxy prints themScience and Medicine (Chair)
The rest of the MBX Biosciences board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Edward T. Mathers | Independent Director | $196,190 |
| Laurie Stelzer | Independent Director | $0 |
| Ora Pescovitz | Independent Director | $198,947 |
| P. Kent Hawryluk | Director | $0 |
| Patrick J. Heron | Independent Director | $220,947 |
| Steven L. Hoerter | Chair of the Board | $999,986 |
| Tiba Aynechi | Independent Director | $200,690 |
The full MBX Biosciences compensation record
free company briefThis page is one director within MBX Biosciences's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat